Immunotherapy responsive neuropathic pain associated with LGI1 and CASPR2 antibodies
Main Authors: | Ramanathan, S, Davies, A, Uy, C, Tseng, M, Paneva, S, Michael, S, Varley, J, Binks, S, Themistocleous, A, Anziska, Y, Candalija, A, Soni, A, Hofer, M, Brilot, F, Dale, RC, Dawes, J, Rinaldi, S, Bennett, D, Irani, SR |
---|---|
Format: | Conference item |
Language: | English |
Published: |
BMJ Publishing Group
2021
|
Similar Items
-
Immunotherapy-resistant neuropathic pain and fatigue predict quality-of-life in contactin-associated protein-like 2 antibody disease
by: Ceronie, B, et al.
Published: (2025) -
Origins and immunopathogenesis of autoimmune central nervous system disorders
by: Ramanathan, S, et al.
Published: (2023) -
Immunotherapy-responsive neuropathic pain and allodynia in a patient with glycine receptor autoantibodies: a case report
by: Soleimani, B, et al.
Published: (2023) -
Immunotherapy in autoimmune encephalitis
by: Trewin, BP, et al.
Published: (2022) -
Patient-derived antibodies reveal the subcellular distribution and heterogeneous interactome of LGI1
by: Ramirez-Franco, J, et al.
Published: (2022)